Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-17-003951

Options or other derivatives

  • Chief Medical Officer, EVP R&D acquired 37,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Taub Rebecca · Chief Medical Officer, EVP R&D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-03-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +37,300 37,300 D
Loading xslF345X03/edgar.xml…